Labeled for this condition
Medicines for psoriasis
38 medicines have an FDA label indicated for psoriasis; 14 are listed from generic labelers and 2 have a presentation in shortage now (FDA files, October 8, 2026).
Which medicines are labeled for psoriasis?
Each label names the condition in its indications; the record shows the label's words. A list of labeled medicines is not a treatment plan.
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Salicylic acid | none listed | none listed | $0.102 per patch Callus removers patch | No | No current entry | 1 |
| Dexamethasone | Ozurdex, Maxidex, Hemady | 60 labelers | $0.193 per tablet 4 mg tablet | No | In shortage | 8 |
| Clobetasol | Byqlovi, Impoyz, Clodan | 39 labelers | $0.126 per gram 0.05% ointment | No | No current entry | 18 |
| Betamethasone | Celestone, Sernivo, Diprolene | 28 labelers | $0.418 per gram 0.05% cream | No | No current entry | 13 |
| Methotrexate | Rasuvo, Otrexup, Jylamvo | 29 labelers | $0.158 per tablet 2.5 mg tablet | Yes | In shortage | 8 |
| Adalimumab | Amjevita, Humira, Hyrimoz | none listed | $1,587.82 per mL 40 mg/0.4 mL | Yes | No current entry | 1 |
| Fluocinolone | Synalar, Derma-Smoothe, Yutiq | 15 labelers | $0.171 per mL 0.01% scalp oil | No | No current entry | 14 |
| Calcitriol | Vectical | 20 labelers | $0.153 per capsule 0.25 mcg capsule | No | A presentation being discontinued | 2 |
| Desoximetasone | Topicort | 13 labelers | $0.369 per gram 0.25% ointment | No | No current entry | 9 |
| Coal tar | none listed | none listed | $0.0088 per mL 0.5% shampoo | No | No current entry | 0 |
| Roflumilast | Zoryve, Daliresp | 15 labelers | $0.311 per tablet 500 mcg tablet | No | No current entry | 0 |
| Acitretin | none listed | 8 labelers | $2.59 per capsule 10 mg capsule | Yes | No current entry | 0 |
| Tazarotene | Tazorac, Arazlo, Fabior | 7 labelers | $6.11 per gram 0.1% gel | No | No current entry | 1 |
| Halobetasol | Bryhali, Ultravate, Lexette | 6 labelers | $0.620 per gram 0.05% ointmnt | No | No current entry | 3 |
| Adalimumab-adbm | Cyltezo | none listed | $639.19 per pen 40 mg/0.4 mL | Yes | No current entry | 0 |
| Adalimumab-ryvk | Simlandi | none listed | $499.12 per unit 40 mg/0.4 mL autoinjector | Yes | A presentation being discontinued | 0 |
| Calcipotriene | Sorilux, Pellix | 6 labelers | $1.05 per gram 0.005% cream | No | No current entry | 1 |
| Betamethasone and calcipotriene | Enstilar, Taclonex, Wynzora | 5 labelers | $1.81 per gram 0.005%-0.064% ointment | No | No current entry | 1 |
| Risankizumab | Skyrizi | none listed | $22,774.36 per mL 150 mg/mL pen | No | No current entry | 0 |
| Apremilast | Otezla | none listed | $90.57 per tablet 30 mg tablet | No | No current entry | 0 |
| Spesolimab | Spevigo | none listed | n/a | No | No current entry | 0 |
| Adalimumab-aaty | Yuflyma | none listed | $495.75 per unit 40 mg/0.4 mL autoinjector | Yes | No current entry | 0 |
| Adalimumab-afzb | Abrilada | none listed | n/a | Yes | A presentation being discontinued | 0 |
| Adalimumab-fkjp | Hulio | none listed | n/a | Yes | No current entry | 0 |
| Corticotropin | Acthar, Purified | none listed | n/a | No | No current entry | 2 |
| Etanercept | Enbrel | none listed | $2,084.14 per mL 25 mg/0.5 mL syringe | Yes | No current entry | 0 |
| Bimekizumab | Bimzelx | none listed | $8,073.83 per mL 160 mg/mL autoinjector | No | No current entry | 0 |
| Ixekizumab | Taltz | none listed | $7,370.72 per mL 80 mg/mL autoinjector | No | No current entry | 0 |
| Secukinumab | Cosentyx | none listed | $3,946.35 per mL 300 mg dose/2 pens (150 mg/pen) | No | No current entry | 0 |
| Certolizumab | Cimzia | none listed | $6,094.02 per syringe 2x200 mg/mL syringe kit | Yes | No current entry | 1 |
| Adalimumab-aacf | Idacio | none listed | n/a | Yes | No current entry | 0 |
| Brodalumab | Siliq | none listed | n/a | Yes | No current entry | 0 |
| Deucravacitinib | Sotyktu | none listed | n/a | No | No current entry | 0 |
| Halobetasol and tazarotene | Duobrii | none listed | n/a | No | No current entry | 0 |
| Icotrokinra | Icotyde | none listed | n/a | No | No current entry | 0 |
| Methoxsalen | none listed | 1 labeler | n/a | Yes | No current entry | 1 |
| Tapinarof | Vtama | none listed | $25.23 per gram 1% cream | No | No current entry | 0 |
| Tildrakizumab | Ilumya | none listed | n/a | No | No current entry | 0 |
Source: FDA drug labels (indications) via openFDA; NDC Directory; CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price